Financial statements Delpharm Investments Poland
Company deleted from KRS: 2025-09-30
Balance sheet data of DELPHARM INVESTMENTS POLAND
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 5 000,00 | 0,00 | 1 776 882,34 | 12 437 895,72 | 12 372 015,02 | 12 311 375,73 |
A. Fixed assets | 0,00 | 0,00 | 1 231 123,50 | 2 308 365,28 | 1 793 955,17 | 1 211 192,59 |
B. Current assets | 5 000,00 | 0,00 | 545 758,84 | 10 129 530,44 | 10 578 059,85 | 11 100 183,14 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
Total liabilities | 5 000,00 | 0,00 | 1 776 882,34 | 12 437 895,72 | 12 372 015,02 | 12 311 375,73 |
A. Equity | 5 000,00 | 0,00 | -72 711,92 | -128 040,14 | 78 533,84 | -431 052,62 |
B. Liabilities and provisions for liabilities | 0,00 | 0,00 | 1 849 594,26 | 12 565 935,86 | 12 293 481,18 | 12 742 428,35 |
I. Long-term liabilities | - | - | - | - | - | - |
II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.